Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D

JAMA Health Forum. 2023 Feb 3;4(2):e225610. doi: 10.1001/jamahealthforum.2022.5610.
No abstract available

Plain language summary

This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.

MeSH terms

  • Insurance Coverage
  • Medicare Part D*
  • Policy
  • Prior Authorization
  • United States